01 August 2022: ReNeuron Group plc (AIM: RENE), a UK-based leader in stem cell derived exosome technologies, announces the appointment of Catherine Isted, ACMA, as Chief Executive Officer (“CEO”), effective 1 September 2022.

Read more…

Back